The global cardiovascular and soft tissue repair patches market size is expected to reach USD 5.71 billion by 2025, at a CAGR 8.2 % over a forecast period, according to a new report by Grand View Research, Inc. Increasing application of these patches in medical procedures and sports injuries and rising prevalence of heart defects such as atrial septal defect and ventricular septal defect are some of the factors driving the demand.
Growing prevalence of Cardiovascular Diseases
(CVDs) is one of the key market drivers. According to the American Heart
Association, cardiovascular diseases accounted for nearly 800,000 deaths in the
U.S. in 2017. Moreover, the prevalence of heart attacks is significantly high
in the country. Nearly, 790,000 U.S. adults suffer from heart attack each year.
Coronary heart diseases account for the majority of CVD deaths followed by
heart attack and stroke. High prevalence of such diseases is anticipated to
create lucrative growth opportunities for the market.
Growing prevalence of hernia is also one of the
key market drivers. Key risk factors for hernia are abdominal surgery, heavy
weight lifting, chronic cough, constipation, ascites (fluid in abdomen), and
other conditions that increase pressure on the intra-abdominal region.
Furthermore, nerve damage, loss of tissue strength, and genetic factors lead to
weakening of muscles. Congenital hernia is due to residual embryological
channel defect and family history. According to a survey, in 2016, around 20
million repairs of inguinal hernia were carried out each year across the globe.
Thus, the demand for these patches in healing the wounds post operation is
anticipated to grow significantly over the years.
Full Research Report On Cardiovascular & Soft Tissue Repair Patches Market
Visit Here:
https://www.grandviewresearch.com/industry-analysis/cardiovascular-soft-tissue-repair-patches-market
Cardiovascular & Soft Tissue Repair Patches Market Report Highlights
- In 2018, soft tissue repair held the largest market share in terms
of revenue owing to the increasing prevalence of hernia
- Cardiac repair segment is expected to witness rapid growth over the
forecast period owing to high prevalence of congenital heart diseases
coupled with improving treatments globally
- ePTFE segment accounted for the largest revenue share of raw
materials in 2018 however biomaterial and tissue engineered materials
segment is expected to register the fastest CAGR over the forecast period
- In 2018, North America held the largest revenue share due to high
prevalence of diseases and easy access of treatment alternatives
- Asia Pacific is expected to emerge at the fastest CAGR over the
forecast period owing to growing prevalence of congenital heart diseases
and hernia
- Key players operating in the cardiovascular and soft tissue repair
patches market include Edwards Life Sciences; Cryolife; Baxter; Bard
Peripheral Vascular Inc.; and W.L.Gore & Associates.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/cardiovascular-soft-tissue-repair-patches-market/request/rs1
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment